SkyCell completes product portfolio with new frozen container for -20°C transport

This container, built on SkyCell’s platform approach, is a game-changer due to its strong performance and lightweight design (only 470kg). The efficient design also leads to a reduction of CO2 emissions by as much as half, as the containers are built from a recyclable multi-layer material. This material absorbs impact and dampens the vibrations from aircraft and trucks that are – along with excursions outside optimal temperature range – a leading cause of in-transit product spoilage. This has led the company to have a verified product loss rate of less than 0.1 per cent.

With this new offering, SkyCell now has a container suited to pharmaceutical product transportation at every temperature range, ensuring current and yet-to-be developed vaccines and other lifesaving medicines can reach destinations around the world safely, securely, and with minimal product loss.

Thanks to advanced CAD design and SkyCell technology the containers can store up to five times more energy than traditional solutions, helping to keep the container at a steady temperature for more than 120h. SkyCell is expected to produce 70-100 units of the 1500F container per month, which, for example, could conceivably deliver enough vaccines to vaccinate a country like Switzerland in one month.